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ABSTRACT
Background: The optimal treatment of empyema tho-
racis has been widely debated.  Proponents of pleural
drainage alone, drainage plus fibrinolytic therapy, video-
assisted thoracoscopic surgical (VATS) debridement, and
open thoracotomy each champion the efficacy of their
approach.
Methods: This study examines treatment of complex
empyema thoracis between June 1, 1994, and April 30,
1997.  Twenty-one men and 9 women underwent 30
drainage/decortication procedures (14 open thoraco-
tomies and 16 VATS) in treatment of their disease.
Effusion etiology was distributed as follows:  infectious -
14; neoplastic-associated - 7; traumatic - 3; other - 6.
Results: The mean preoperative hospital stay was 14 ±
8.8 days, (11.4 ± 6.5 days for VATS vs 16.8 ± 10.2 days
for thoracotomy).  Hospital stay from operation to dis-
charge for thoracotomy patients was 10.0 ± 7.2 days
(median 8.5 days) and for VATS patients 17.6 ± 16.8 days
(median 11 days).  These differences were not statistical-
ly significant.  Duration of postoperative thoracostomy
tube drainage was 8.3 ± 4.6 days for thoracotomy
patients and 4.7 ± 2.8 days in the VATS group (p = 0.01).
Operative time for the thoracotomy group was 125.0 ±
71.7 minutes, while the VATS group time was only 76.2
± 30.7 minutes.  Estimated blood loss for the thoracoto-
my group was 313.9 ± 254.0 milliliters and for the VATS
group 131.6 ± 77.3 milliliters.  Three of the 30 patients
(10.0%) required prolonged ventilator support (>24
hours).  Morbidity included one diaphragmatic laceration
(VATS group) and one thoracic duct laceration (thoraco-
tomy).  Two VATS procedures (6.7%) required conver-
sion to open thoracotomy for thorough decortication.
INTRODUCTION
Treatment options for management of empyema thoracis
have been recently reviewed by several groups.1-3  While
general agreement exists for treatment of thin, exudative
effusions by simple thoracentesis or tube thoracostomy,
controversy arises as to the optimal approach to diagno-
sis and treat the fibrinopurulent and organize phases of
the disease.  Early reports4 suggesting use of VATS tech-
niques to treat pleural empyema have only recently
appeared in the literature.
Preoperative evaluation of empyema includes recogni-
tion of symptoms, chemical and microbiologic analysis of
pleural fluid and radiographic investigation.  A pro-
longed interval between hospital admission and institu-
tion of definitive therapy often occurs, thus allowing fur-
ther organization of an already loculated cavity.
Classic treatment of empyema with repeated thoracente-
sis or tube thoracostomy is fraught with persistent inad-
equate thoracic drainage.  This issue has been addressed
from the pharmacological perspective with instillation of
the fibrinolytic agent streptokinase to promote thrombus
dissolution.  Advances in thoracic radiology permit pre-
cise drainage catheter positioning with low attendant
morbidity.  Finally, refinement of VATS techniques facili-
tates a minimally invasive surgical access portal to the
thorax for exploration, debridement and drainage.
The utility of VATS continues to evolve from a modality
principally of pleural evaluation to an accepted means of
definitive surgical treatment of complex intrathoracic
pathology.  This study group examines a series of
patients with complex empyema thoracis.  A comparison
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of preoperative diagnostic modalities, etiology of the dis-
ease, method of treatment and postoperative care is ana-
lyzed to determine if VATS is a viable treatment alterna-
tive to open thoracotomy.
METHODS
Patient Selection
This study is a review of all surgically treated cases of
empyema thoracis performed at either the University of
Illinois at Chicago Hospital or the Veterans Administration
Westside Medical Center by one surgeon (WTV) between
June 1, 1994, and April 30, 1997.  All patients treated by
the thoracic surgical service during this time period were
included in the study group.  A total of 30 patients with
complex empyema thoracis in 9 women and 21 men
were treated.  The open thoracotomy group consisted of
14 patients, 12 men and 2 women, with an average age
of 50.9 years (range 27-74 years).  The VATS group con-
sisted of 16 patients, 9 men and 7 women, with an aver-
age age of 51.6 years (range 27-73 years) (Table 1). 
All cases were evaluated and managed preoperatively by
the general medical service.  Chest radiography was uni-
formly performed; computed tomography was obtained
in 25 patients.  Thoracentesis was performed in 22
patients (10/14 in the open group and 12/16 in the VATS
group); all studies were done by either the medical or
pulmonary service.  Preoperative bronchoscopy was
done in only six patients.  The time between hospital
admission and surgical intervention was determined by
when the medical service requested a surgical consulta-
tion.  Once consulted, most patients underwent decorti-
cation the following day.  Average preoperative hospital
stay was 13.9 ± 8.8 days, 11.4 ± 6.5 days for the VATS
group and 16.8 ± 10.2 days for the thoracotomy group
(Table 2).
Operative Procedure 
All patients underwent general endotracheal anesthesia
with a double lumen tube to facilitate single-lung venti-
lation.  Thoracic epidural infusion catheters were placed
in 26 (86.7%) patients for management of visceral pain
that generally accompanies parietal pleural stripping
from the inner surface of the thoracic cavity.  Open tho-
racotomy patients underwent a serratus muscle-sparing
lateral thoracotomy.  Those patients undergoing VATS
had placement of three 10-mm ports, most often one in
the anterior, mid and posterior axillary line to form a tri-
angle whose apex was directed toward the anterior supe-
rior iliac spine.
Debridement of the visceral and parietal pleural surfaces
was performed bluntly with ring forceps or a metal-
tipped suction and sharply with endoscopic or conven-
tional scissors.  Inadequate VATS visualization of the tho-
racic cavity required conversion to an open procedure in
two patients (6.7%).  Two – 32 French thoracostomy
drainage tubes were placed under direct vision prior to
wound closure.
All patients were managed postoperatively by the tho-
racic surgical service.  Criterion for thoracostomy tube
removal in both groups was the absence of an air leak
and less than 50 mL of drainage during the preceding 24
hours.  Patients not ready for discharge from the hospi-
Table 1.  
Patient Demographics.
Group
Open Thoracotomy VATS
Number of Patients 14 16
Sex Distribution 12 male:2 female 9 male:7 female
Average Age 50.9 years 51.6 years
Preop hospital stay 16.8 ± 10.2 days 11.4 ± 6.5 days
Etiology
Infectious 6 8
Neoplastic 2 5
Traumatic 2 1
Other 4 2
Table 2.  
Preoperative Evaluation.
Group
Open Thoracotomy VATS
Chest Radiograph 14/14 16/16
Computed Tomography 12/14 13/16
Thoracentesis 10/14 12/16
Bronchoscopy 01/14 05/14tal after chest tube removal due to other comorbid con-
ditions were transferred back to their referring service.
Statistics
Comparison of group means was performed using the
Student’s paired t-test with p < 0.05 considered as signif-
icant.
RESULTS
Twenty-one men and 9 women underwent 30
drainage/decortication procedures (14 open thoraco-
tomies and 16 VATS) in treatment of their disease.
Effusion etiology was distributed as follows:  infectious
(as defined by pH and glucose parameters from thora-
centesis specimens) - 14; neoplastic-associated - 7; trau-
matic - 3; other (effusions with a negative culture result
and not meeting the pH and glucose parameters for clas-
sification as “infectious”) - 6.  Culture results in the
patients with infectious empyemas included negative cul-
ture - 6, Strept. Pneumoniae - 4, Staph. Aureus - 2,
Pseudomonas aeruginosa - 2.  Neoplasms encountered
included lung (primary), breast, kidney, and mesothe-
lioma.  
Mean duration of hospital stay from operation to dis-
charge for thoracotomy patients was 10.0 ± 7.2 days
(median 8.5 days) and for VATS patients 17.6 ± 16.8 days
(median 11 days, p = 0.26).  Duration of postoperative
thoracostomy tube drainage was 8.3 ± 4.6 days for tho-
racotomy patients and 4.7 ± 2.8 days in the VATS group
(p = 0.01).  Operative time for the thoracotomy group
was 125.0 ± 71.7 minutes while the VATS group time was
only 76.2 ± 30.7 minutes.  Estimated blood loss for the
thoractomy group was 313.9 ± 254.0 milliliters and for
the VATS group 131.6 ± 77.3 milliliters.  Three of the 30
patients (10.0%) required prolonged ventilator support
(>24 hours).  Morbidity included one diaphragmatic lac-
eration in the VATS group and one thoracic duct lacera-
tion in the thoracotomy group.  Two VATS procedures
(6.7%) required conversion to open thoracotomy to facil-
itate thorough decortication.  
DISCUSSION
The increasing utility of VATS techniques has been rec-
ognized by various investigators in the treatment of pleu-
ral effusions, hydrothorax, bullous and diffuse emphyse-
ma, evaluation of pleural and lung masses and resection
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of mediastinal tumors.  In addition to providing excellent
intrathoracic exposure, VATS has the advantage of incur-
ring less tissue disruption than open thoracotomy.  These
factors have made it an attractive alternative for investi-
gation as a means of treatment for empyema thoracis.
In their retrospective series of 64 cases of loculated
postpneumonic empyemas, Mackinlay et al1 compared
formal thoracotomy and thoracoscopic techniques of
treatment.  Mean postoperative length of medical man-
agement (11.5 vs 17 days) and chest tube removal (4.3 vs
6.1 days) was significantly shorter in the VATS group.  In
contrast to our findings, their operative time for both
approaches was roughly equivalent.  They reported a
10% conversion rate from VATS to open thoracotomy that
approximates our data (6.7% in our study).  Striffeler5 et
al attribute their 28% conversion rate from VATS to an
open procedure in the treatment of fibrinopurulent
empyema to advanced stage disease.
The most frequently isolated microorganisms from adult
pleural empyema cavity fluid cultures are Staphylococcus
aureus or Streptococcus pneumoniae.6 Current treatment
algorithms with early intensive antibiotic therapy fre-
quently sterilize but do not obliterate empyema cavities.
Thus, most series of VATS pleural debridement report
positive pleural culture results in less than 40% of
patients.
Wait  et al7 and his group from Parkland Memorial
Hospital examined pleural drainage and fibrinolytic ther-
apy versus VATS in the treatment of empyema thoracis.
Primary success rate in the VATS group was 91%, while
drainage and fibrinolytics were only primarily successful
in less than one-half of cases.  Duration of chest tube
drainage post-treatment was 5.8 days in the VATS group
(equivalent to our findings) versus 9.8 days in the
drainage/fibrinolytic group.  The total number of hospi-
tal days in their VATS group was significantly less than
with drainage/fibrinolysis (8.7 vs 12.8 days).
More recently, Lawrence et al8 examined 44 patients at
their institution who, over a three-year period, presented
with empyema thoracis.  Thirty of the 42 eligible patients
were treated successfully with VATS techniques; the
remaining twelve patients needed second procedures
(this constituted their open thoracotomy group) for
definitive treatment of their empyema.  Thoracostomy
tube drainage times of 4.0 days versus 8.5 days for the
VATS and open groups, respectively, approximate our290 JSLS(2000)4:287-290
findings.  Duration of stay in their open group is signifi-
cantly longer than in the VATS group (10.3 vs 5.3 days),
although the impact on hospital stay duration of patients
in the open thoracotomy group having had two proce-
dures can be questioned.
Most authors agree that one of the major hurdles in opti-
mal management of empyema thoracis, be it with formal
thoracotomy or VATS techniques, is the delay between
diagnosis and treatment.  Given the efficacy of modern
antibiotic therapy, over half of decortications performed
show no growth of bacteria from intraoperative cultures.
By the time surgical intervention is undertaken, several
weeks have passed, and the exudative stage of the
empyema has evolved into a more chronic fibrinous
process.  Associated comorbidities become more com-
mon as the patient’s illness is transformed from a poten-
tially limited one to a chronic disease state.  Malnutrition,
generalized physical deconditioning, prolonged atelecta-
sis with abscess formation, deep venous thrombosis from
inactivity and superinfections from chronic antibiotic
administration deleteriously affect the hospital course.
In our series of patients, those treated with the VATS tech-
nique had a longer overall hospital stay than their formal
thoracotomy counterparts (although not statistically sig-
nificant).  This is likely attributable to the referral of
cachetic, immunocompromised, ventilator-dependent
patients to us for treatment of empyema thoracis.  These
patients, who would ordinarily be declined for open sur-
gical intervention, were treated successfully by us using
VATS techniques.  Their coexisting morbidities frequently
resulted in prolonged hospital stays long after thoracos-
tomy drainage tubes had been removed.
Video-assisted thoracoscopic surgical technique is a
viable alternative to open thoracotomy in the treatment of
complex empyema thoracis.  All major studies demon-
strate that duration of thoracostomy tube drainage is
shorter in VATS groups, and most (in the absence of seri-
ous comorbidities) have shown a shorter postoperative
hospital stay.  We would, therefore, recommend VATS as
an early therapeutic approach rather than a late salvage
treatment for this often-neglected surgical problem.  
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